Risk factors of multidrug-resistant tuberculosis: A global systematic review and meta-analysis

Journal of Infection - Tập 77 - Trang 469-478 - 2018
Ivan Surya Pradipta1,2,3, Lina Davies Forsman4,5, Judith Bruchfeld4,5, Eelko Hak1, Jan-Willem Alffenaar3
1University of Groningen, Groningen Research Institute of Pharmacy, Unit of Pharmaco-Therapy, -Epidemiology and -Economics (PTE2), Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands
2Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Indonesia
3University of Groningen, University Medical Centrum Groningen, Department of Clinical Pharmacy and Pharmacology, The Netherlands
4Unit of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
5Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden

Tài liệu tham khảo

WHO. WHO Global tuberculosis report 2017. 2017.

WHO. WHO | Global tuberculosis report 2016. 2015.

Mǘller, 2013, The heterogeneous evolution of multidrug-resistant mycobacterium tuberculosis, Trends Genet, 160, 10.1016/j.tig.2012.11.005

Singh, 2015, Prevalence of adverse drug reaction with first-line drugs among patients treated for pulmonary tuberculosis, Clin Epidemiol Glob Heal, 10.1016/j.cegh.2015.10.005

2014, Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis

Hang, 2013, Primary drug-resistant tuberculosis in Hanoi, Viet Nam: present status and risk factors, PLoS One, 8, 1, 10.1371/journal.pone.0071867

Fox, 2011, Comparison of isoniazid monoresistant tuberculosis with drug-susceptible tuberculosis and multidrug-Resistant tuberculosis, Eur J Clin Microbiol Infect Dis, 30, 863, 10.1007/s10096-011-1167-4

Vadwai, 2012, Determination of risk factors for isoniazid monoresistance and multidrug-resistant tuberculosis in treatment failure patients, Scand J Infect Dis, 44, 48, 10.3109/00365548.2011.611169

Chuchottaworn, 2015, Risk factors for multidrug-resistant tuberculosis among patients with pulmonary tuberculosis at the central chest institute of Thailand, PLoS One, 10, 1, 10.1371/journal.pone.0139986

Elmi, 2015, Multidrug-resistant tuberculosis and risk factors associated with its development: a retrospective study, J Infect Dev Ctries, 9, 1076, 10.3855/jidc.6162

Diandé, 2009, Risk factors for multidrug-resistant tuberculosis in four centers in Burkina Faso, West Africa, Microb Drug Resist, 15, 217, 10.1089/mdr.2009.0906

Zhao, 2012, Social behaviour risk factors for drug resistant tuberculosis in mainland China: a meta-analysis, J Int Med Res, 40, 436, 10.1177/147323001204000205

Cai, 2015, Meta-analysis on risk factors of multidrug resitant tuberculosis in China, Chin J Epidemiol, 36, 1424

Faustini, 2006, Risk factors for multidrug resistant tuberculosis in Europe: a systematic review, Thorax, 61, 158, 10.1136/thx.2005.045963

Lukoye, 2015, Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis, BioMed Cent, 15, 1/13

Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS Med, 6, 10.1371/journal.pmed.1000097

Engering, 2013, Pathogen-host-environment interplay and disease emergence, Emerg Microbes Infect, 10.1038/emi.2013.5

Sim, 2005, The kappa statistic in reliability studies: use, interpretation, and sample size requirements, Phys Ther, 85, 257, 10.1093/ptj/85.3.257

Kim, 2013, Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity, J Clin Epidemiol, 66, 408, 10.1016/j.jclinepi.2012.09.016

Higgins, 2011, Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011], Cochrane Collab, 0, 10

Sedgwick, 2013, Meta-analyses: heterogeneity and subgroup analysis, Bmj, 346, 1

de Souza, 2006, Multidrug-resistant Mycobacterium tuberculosis at a referral center for infectious diseases in the state of Minas Gerais, Brazil: sensitivity profile and related risk factors, J Bras Pneumol, 32, 430

El Sahly, 2006, Drug-resistant tuberculosis: a disease of target populations in Houston, Texas, J Infect, 53, 5, 10.1016/j.jinf.2005.10.002

Baghaei, 2009, Risk factors associated with multidrug-resistant tuberculosis, Tanaffos, 8, 17

Mor, 2014, Drug-resistant tuberculosis in Israel: risk factors and treatment outcomes, Int J Tuberc Lung Dis, 18, 1195, 10.5588/ijtld.14.0192

Ahmad, 2012, Risk factors for multidrug-resistant tuberculosis in urban Pakistan: a multicenter case-control study, Int J Mycobacteriology, 1, 137, 10.1016/j.ijmyco.2012.07.007

Mohd, 2016, Previous treatment, sputum-smear nonconversion, and suburban living: the risk factors of multidrug-resistant tuberculosis among Malaysians, Int J Mycobacteriol, 5, 51, 10.1016/j.ijmyco.2015.11.001

Zhao, 2012, National survey of drug-resistant tuberculosis in China, N Engl J Med, 366, 2161, 10.1056/NEJMoa1108789

Shen, 2009, Drug-resistant tuberculosis in Shanghai, China, 2000-2006: Prevalence, trends and risk factors, Int J Tuberc Lung Dis, 13, 253

Balaji, 2010, Risk factors for MDR and XDR-TB in a tertiary referral hospital in India, PLoS One, 5, 1, 10.1371/journal.pone.0009527

Parwati, 2010, Mycobacterium tuberculosis Beijing genotype is an independent risk factor for tuberculosis treatment failure in Indonesia, J Infect Dis, 201, 553, 10.1086/650311

Lan, 2003, Mycobacterium tuberculosis Beijing genotype and risk for treatment failure and relapse, Vietnam, Emerg Infect Dis, 1633, 10.3201/eid0912.030169

Drobniewski, 2005, Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia, Jama, 293, 2726, 10.1001/jama.293.22.2726

Dormans, 2004, Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different mycobacterium tuberculosis genotypes in a BALB/c mouse model, Clin Exp Immunol, 137, 460, 10.1111/j.1365-2249.2004.02551.x

Parwati, 2010, Possible underlying mechanisms for successful emergence of the mycobacterium tuberculosis Beijing genotype strains, Lancet Infect Dis, 103, 10.1016/S1473-3099(09)70330-5

Suchindran, 2009, Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic review, PLoS One, 10.1371/journal.pone.0005561

Houben Rein, 2011, Human immunodeficiency virus associated tuberculosis more often due to recent infection than reactivation of latent infection, Int J Tuberc Lung Dis, 15, 24

Aaron, 2004, Tuberculosis in HIV-infected patients: a comprehensive review, Clin Microbiol Infect, 10, 388, 10.1111/j.1469-0691.2004.00758.x

Zhao, 2015, Multidrug-resistant tuberculosis in patients with chronic obstructive pulmonary disease in China, PLoS One, 10, 10.1371/journal.pone.0135205

Inghammar, 2010, COPD and the risk of tuberculosis - a population-based cohort study, PLoS One, 5, 7, 10.1371/journal.pone.0010138

Kim, 2013, Inhaled corticosteroid is associated with an increased risk of TB in patients with COPD, Chest, 143, 1018, 10.1378/chest.12-1225

Srivastava, 2011, Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability, J Infect Dis, 204, 1951, 10.1093/infdis/jir658

Pasipanodya, 2012, Meta-analysis of clinical studies supports the pharmacokinetic variability hypothesis for acquired drug resistance and failure of antituberculosis therapy, Clin Infect Dis, 169, 10.1093/cid/cis353

Ramachandran, 2012, Role of pharmacogenomics in the treatment of tuberculosis: a review, Pharmgenomics Pers Med, 89

Nahid, 2016, Official American thoracic society / centers for disease control and prevention / infectious diseases society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis, Clin Infect Dis Guidel, 63, 147, 10.1093/cid/ciw376

Andrews, 2010, Predictors of multidrug-and extensively drug-resistant tuberculosis in a high HIV prevalence community, PLoS One, 5, 1, 10.1371/journal.pone.0015735

Ferro, 2011, Multidrug-resistant mycobacterium tuberculosis, southwestern Colombia, Emerg Infect Dis, 17, 1259, 10.3201/eid1707.101797

Gao, 2016, Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with standard short-course chemotherapy for tuberculosis, BMC Pulm Med, 16, 26, 10.1186/s12890-016-0187-3

He, 2011, Multidrug-resistant tuberculosis, People's Republic of China, 2007–2009, Emerg Infect Dis, 17, 1831, 10.3201/eid1710.110546

O'Riordan, 2008, Rapid molecular detection of rifampicin resistance facilitates early diagnosis and treatment of multi-drug resistant tuberculosis: case control study, PLoS One, 3, 1, 10.1371/journal.pone.0003173

Thông tin
Thông tin xuất bản

Journal of Infection

Tập 77

469-478

Thông tin tác giả